Skip to main content
logo
Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.050
0.00 (0.00%)
Aug 6, 2026, 4:00 PM EDT - Market closed

Pliant Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---1.589.697.57
Revenue Growth
----83.69%27.91%-81.89%
Gross Profit
---1.589.697.57
Operating Income
-119.21-156.37-228.37-184.15-127.2-97.54
Net Income
-113.22-149.34-210.3-161.34-123.32-97.26
Earnings Per Share
-1.84-2.43-3.47-2.75-2.94-2.71
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
170.89190.94355.72494.25331.19200.6
Total Debt
28.7829.1160.1911.3715.827.19
Net Cash (Debt)
142.11161.84295.53482.87315.37193.4
Net Cash Growth
-42.11%-45.24%-38.80%53.11%63.07%-30.15%
Net Cash Per Share
2.312.644.888.227.515.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-98.7-128.34-155.5-116.36-94.63-75.44
Capital Expenditures
-0.11-0.37-3.85-0.92-1.76-1.95
Free Cash Flow
-98.81-128.71-159.35-117.28-96.39-77.4
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----11654.70%-1313.37%-1288.10%
Pretax Margin
----10211.14%-1273.32%-1284.51%
Profit Margin
----10211.10%-1273.32%-1284.51%
FCF Margin
----7422.91%-995.26%-1022.13%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---686.8297.6864.33